Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, FDA

Syntr Health Technologies Announces FDA Clearance of the SyntrFuge System for use in Specialty Surgeries Requiring Transfer and Implantation of Patient's Own Fat Tissue


IRVINE, Calif., Aug. 12, 2021 /PRNewswire/ -- Syntr Health Technologies, Inc., a medical device company specializing in the processing of autologous adipose tissue, also known as fat tissue, today announced clearance from the US Food & Drug Administration (FDA) for the company's patented SyntrFuge Systemtm for use in surgical specialties when the transfer of harvested adipose (fat) tissue is desired. These specialties include orthopedic, arthroscopic, neurosurgery, gastrointestinal, urological, general, gynecological, thoracic, laparoscopic, and plastic and reconstructive surgeries when aesthetic body contouring is desired.

In a separate release today, the company also announced an oversubscribed $2.2 million seed investment round.

"As a bootstrapped company with limited funding, Syntr Health Technologies achieved a major milestone, gaining FDA clearance for our innovative, effective, and affordable approach for accelerating adipose tissue processing at the point of care," said Ahmed Zobi, Syntr Chief Executive Officer. "We look forward to building out sales of the SyntrFuge System and further expanding our product line to a broad range of markets."

The SyntrFuge System concentrates fat tissue while preserving the cell structure and cell viability, which are critical for the adipose tissue to function naturally in the body. The concentrated fat produced by the SyntrFuge System is ideal for use in aesthetic applications and expanding options for patients who may not want, or who are not candidates for major and more invasive surgeries. The implantation of adipose tissue is known to aid in the natural rejuvenation of soft tissue in plastic and reconstructive surgery.

In conjunction with today's announcement, Syntr released and listed with FDA its Class I SyntrFPU 360 device, a lab centrifuge device that facilitates expedited processing, as an accessory to the SyntrFuge System.

About Syntr Health Technologies, Inc.
Irvine, California-based Syntr Health Technologies, Inc. was founded by three engineers and incorporated in 2018, following the successful grant of an NIH Phase I SBIR (Small Business Innovation Research). The company's mission is to assist physicians with a device that accelerates adipose tissue processing at the point of care.  Syntr Health Technologies is focused on becoming the market leader in automated adipose tissue processing, reducing recovery times, and improving quality of life.  Syntr is headquartered at University Lab Partners, a premier wet lab incubator in the heart of Orange County.

About University Lab Partners 
University Lab Partners is a premier, nonprofit, wet lab incubator located in UCI Research Park in Irvine, CA. ULP is a professionally managed and equipped wet lab facility along with the benefits of peer-to-peer interactions among a life science-focused entrepreneurial community. ULP is a project of The Beall Family Foundation.

 

SOURCE University Lab Partners


These press releases may also interest you

15 oct 2021
Helix BioPharma Corp. ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announced today that it anticipates the filing of its annual financial...

15 oct 2021
The Centers for Medicare and Medicaid Services (CMS) released its annual quality rankings. For the 2022 plan year, Network Health earned a 5 out of 5-Star Rating from CMS for its Medicare Advantage PPO plans. This is Medicare's highest possible...

15 oct 2021
Boehringer Ingelheim today announced the U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License Application (sBLA) for Cyltezo® (adalimumab-adbm) as the first Interchangeable biosimilar with Humira® (adalimumab). The FDA...

15 oct 2021
Novartis Pharmaceuticals Canada Inc. applauds the government of Quebec's decision to provide public reimbursement for Zolgensma® (onasemnogene abeparvovec)...

15 oct 2021
Worcester Polytechnic Institute (WPI) researcher Loris Fichera has developed a flexible, slimmed-down robotic laser probe for endoscopic larynx surgeries that could reduce recovery time for patients and cut health care spending by shifting procedures...

15 oct 2021
The "Global Industrial Radiography Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technique (Film-based Radiography and Digital Radiography); End-User Industry" report has been added to ResearchAndMarkets.com's offering. The...



News published on 12 august 2021 at 06:00 and distributed by: